The largest database of trusted experimental protocols

Flp in t rex cell line development

Manufactured by Thermo Fisher Scientific

The Flp-In™ T-REx cell line development system is a tool for generating stable, inducible mammalian cell lines. It provides a platform for controlled expression of genes of interest in a range of cell types.

Automatically generated - may contain errors

2 protocols using flp in t rex cell line development

1

Tetracycline-Inducible CSNK2A1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human adenocarcinoma HeLa Tet-Off (HeLaT, Clontech) and osteosarcoma U2OS derived cells expressing the tetracycline responsible element (U2OS, gift from Dr. Christoph Englert, Forschungszentrum Karlsruhe, Germany (Englert et al., 1995 (link))), or U2OS cells expressing the tetracycline responsible element of Flp-In™ T-REx system (FT-U2OS, gift from Karmella Haynes, Arizona State University (Haynes and Silver, 2011 (link))) were cultured in Dulbecco’s Modified Eagle’s medium (DMEM, Wisent) supplemented with 10% fetal bovine serum (FBS, HyClone), 100 μg/ml streptomycin and 100 units/mL penicillin (Thermo) at 37 °C with 5% CO2 in 10 or 15 cm dishes (TPP, FroggaBio), 6- or 12-well plates (Greiner Bio-One). Following the recommendations of Flp-In™ T-REx cell line development of Thermo Fisher Scientific (www.thermofisher.com) we developed and characterized FT-U2OS cell lines stably expressing the wild type CSNK2A1-WT (C-terminal HA tag) or inhibitor-resistant forms of triple mutant CSNK2A1-TM (V66A/H16D/I174A, C-terminal HA tag) with tight tetracycline regulation.
+ Open protocol
+ Expand
2

Tetracycline-Inducible U2OS Cell Line for CSNK2A1 Kinase Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human osteosarcoma U2OS cells expressing the tetracycline responsible element of Flp-In™ T-REx system (FT-U2OS, gift from Karmella Haynes, Arizona State University, (Haynes and Silver, 2011 (link))) were cultured in Dulbecco’s Modified Eagle’s medium without sodium pyruvate, L-Arg, and L-Lys (DMEM, Wisent) supplemented with 10% of 10 kDa cut-off fetal bovine serum (Wisent), 100 μg/mL streptomycin, 100 units/mL penicillin (Thermo), 15 μg/mL blasticidin (Wisent), and 150 μg/mL hygromycin B (Wisent). The cell media was also supplemented with 0.398 mM L-Arg, 0.274 mM L-Lys, and 3.47 mM L-Pro. The cells were grown at 37°C with 5% CO2 in 10 cm dishes (TPP, FroggaBio) or in 6-well plates (Greiner BioOne). Following the recommendations of Flp-In™ T-REx cell line development of ThermoFisher Scientific (http://www.thermofisher.com/), we developed cell lines stably expressing the wild-type CSNK2A1-HA (WT) or the inhibitor resistant forms of double mutant (DM, V66A/I174A) of the kinase with tight tetracycline regulation. The exogenous CSNK2A1 has a C-terminal HA tag to be able to distinguish from the endogenous kinase. The cell lines were induced 48h prior to inhibitor treatment with 1 μg/mL tetracycline and were kept induced during the inhibitor treatment. Cells were challenged in two independent experiment with a range of inhibitor concentrations as indicated in the figures.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!